Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening

Eur J Med Chem. 2017 Mar 31:129:275-286. doi: 10.1016/j.ejmech.2017.02.020. Epub 2017 Feb 9.

Abstract

The cyclin dependent kinase CDK8, along with Med12 and Med13, form the kinase module of the Mediator complex. CDK8 expression associates with the activation of β-catenin in colon and gastric cancers. Herein, we applied docking-based virtual screening (VS) using the multiple crystal structures to identify several potent CDK8 inhibitors. The appropriate use of multiple crystal structures obtained a better enrichment of CDK8 conformations to cope with the protein flexibility. Later on, the 2D similarity search was used to find the derivatives of the high inhibitory CDK8 inhibitors we discovered by VS. Finally, we measured the dose response behaviors, the IC50 values of compound W-34, W-37, W-8, WS-2 are 6.5 nM, 36 nM, 93 nM, 9 nM, respectively. These novel leads provided good starting points to design and synthesis a series of highly selective and potent CDK8 inhibitors.

Keywords: 2D similarity search; CDK8 inhibitors; Cyclin C; Molecular docking; Virtual screen.

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Crystallization
  • Cyclin-Dependent Kinase 8 / antagonists & inhibitors*
  • Drug Discovery
  • Drug Screening Assays, Antitumor / methods*
  • Humans
  • Mediator Complex
  • Molecular Docking Simulation
  • Molecular Structure
  • Protein Kinase Inhibitors / chemistry*
  • Protein Kinase Inhibitors / pharmacology
  • User-Computer Interface
  • beta Catenin / metabolism

Substances

  • Antineoplastic Agents
  • MED12 protein, human
  • MED13 protein, human
  • Mediator Complex
  • Protein Kinase Inhibitors
  • beta Catenin
  • Cyclin-Dependent Kinase 8